Events › B2B Event
B2B Event
The Advanced Cancer Therapies (ACT) meeting by the Society of Surgical Oncology focuses on emerging cancer treatments, targeted therapies, and multidisciplinary care for healthcare professionals.
Exhibitor mix: Categorized by supporter level (Platinum, Gold, Bronze, etc.)
Filter this event to your ICP.
Dozens of solution providers here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Organizer
Society of Surgical Oncology
Nonprofit · Rosemont, United States · Founded 1940
A professional organization advancing the science and practice of cancer surgery through education and research.
Why people attend
To learn about the latest clinical trial results, novel therapeutics, and network with leading surgical oncologists.
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
23 speakers at Advanced Cancer Therapies
CSSO
"GP9: Immigrant Women’s Breast Cancer Treatment Experience in a Canadian Healthcare System: A Qualitative Study"
ESSO
"GP6. Evaluating the Safety of Sentinel Node Biopsy Omission in Early-Stage Invasive Lobular Carcinoma"
ESSO
"GPA7. Drain-free Mastectomy and Flap Fixation – the Final Analysis of the Randomised Controlled Non-inferiority SARA-trial."
ESSO
"GPA2. Long-term changes in Quality of Life and Bowel Function in Rectal Cancer Patients Managed with a Watch-and-Wait Strategy After Clinical (Near-)Complete Response"
IASO
"GP8: The Nodal Nexus: Unraveling the Lymph Node Dynamics and Outcomes in Node-Positive Carcinoma Penis"
IASO
"GP3. From Scalpel to Slide: The Enigma of Tumor Margin Shrinkage in Oral Cancer Resection"
"Understanding the Correlation Between Social Determinants of Delays in Diagnosis Management and Outcomes for Solid Cancers in Tamil Nadu – A Multicentric Mixed Method Study"
IASO
"GPA6. Delta by CROSS, Can Metabolic Response Predict Complete Pathologic Response and Survival in Locally Advanced Squamous Cell Carcinoma Oesophagus Treated as Per CROSS?"
IASO
"GPA10. Clinicopathological Profile And Prognosis Of Primary Mediastinal Germ Cell Tumors – A Tertiary Care Centre Experience"
IASO
"GPA11. Fostering Change in Knowledge, Attitude, Perception and Perceived Usability of Robotic Surgery: Insights from a One-Day Simulation-Based Workshop for Medical Students"
IASO
"GPA4. No-Doppler Chest Wall Perforator Flaps (CWPFs) for Partial Breast Reconstruction: Surgical and Patient-Reported Outcomes from a Tertiary Cancer Center in India"
"GPA1. Functional Outcomes of Infrahyoid Flap Reconstruction in Oral Cavity Malignancies – (93 Cases From a Tertiary Care Centre)CASES IN A TERTIARY CARE CENTER"
IASO
"GPA9. Factors Predicting Inoperability in Radiologically Resectable Gallbladder Malignanciesresectable Gallbladder malignancies"
IASO
"GPA5. From Inoperable to Resectable: Redefining Surgical Boundaries in Thymic Malignancies with Neoadjuvant Chemotherapy"
IASO
"GPA12. Towards Safer Exenterations – Predictive Risk Factors for Major Complications in Pelvic Exenteration Surgeries"
JSGS
"GP1. Digital biopsy of high-grade colorectal cancer with Radiomics using preoperative PET"
+ 7 more speakers at this event.
More events in United States
Frequently asked questions